Metabolic syndrome and breast cancer survivors: a follow-up analysis after completion of chemotherapy

Metabolic syndrome and breast cancer survivors: a follow-up analysis after completion of chemotherapy

Background: We previously reported that (neo)adjuvant chemotherapy adversely altered metabolic syndrome (MetS) components, body composition, and related biomarkers after a 12 to 18-week chemotherapy treatment course in women. Here, we sought to determine whether these measures worsened within 4–5 ye...

Full description

Bibliographic Details
Main Authors: Dieli-Conwright, C.M (Author), Mortimer, J.E (Author), Waliany, S. (Author), Wong, L. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
adult
antineoplastic agent
Article
Biomarkers
body composition
body fat
body weight
Body weight
breast cancer
Breast cancer
C reactive protein
cancer chemotherapy
cancer staging
cancer survivor
Caucasian
cholesterol blood level
clinical article
drug effect
fat mass
female
follow up
glucose metabolism
groups by age
hemoglobin A1c
hemoglobin blood level
Hispanic
HOMA index
human
insulin
lipid fingerprinting
low density lipoprotein cholesterol
Metabolic syndrome
metabolic syndrome X
middle aged
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items